Stay updated on Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial

Sign up to get notified when there's something new on the Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1, indicating a new release. The Back to Top link has been removed.
    Difference
    0.1%
    Check dated 2025-09-14T07:48:14.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of specific facility names and locations, as well as a new reference to a medical study on BRAF-MEK inhibition in craniopharyngiomas. Additionally, several previous location and disease-related terms have been removed.
    Difference
    4%
    Check dated 2025-09-07T00:56:42.000Z thumbnail image
  3. Check
    23 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T17:48:04.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T14:40:23.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.8%
    Check dated 2025-08-02T13:36:55.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about HHS Vulnerability Disclosure.
    Difference
    0.1%
    Check dated 2025-07-26T12:06:19.000Z thumbnail image

Stay in the know with updates to Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vemurafenib & Cobimetinib in BRAF V600E Craniopharyngioma Clinical Trial page.